Belite Bio, Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 167,930 | $10.60 M | 100.00% | 0.55% |
| STATE STREET CORP | 02/14/2025 | 20,017 | $1.26 M | -0.34% | 0.07% |
| JPMORGAN CHASE & CO | 02/12/2025 | 14,636 | $923,532 | 130.27% | 0.05% |
| UBS GROUP AG | 02/14/2025 | 12,207 | $770,262 | 9,436.72% | 0.04% |
| XTX TOPCO LTD | 02/13/2025 | 7,062 | $445,612 | 30.92% | 0.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 6,700 | $422,770 | 0.00% | 0.02% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 6,326 | $399,171 | 100.00% | 0.02% |
| MARSHALL WACE, LLP | 02/13/2025 | 5,865 | $370,081 | -30.89% | 0.02% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 2,450 | $154,595 | 100.00% | 0.01% |
| RHUMBLINE ADVISERS | 01/30/2025 | 1,435 | $90,548 | 0.00% | 0.00% |
| GAMMA INVESTING LLC | 01/03/2025 | 1,290 | $81,399 | 48.11% | 0.00% |
| VIRTUS ETF ADVISERS LLC | 02/14/2025 | 1,122 | $70,798 | -39.12% | 0.00% |
| ADVISORS PREFERRED, LLC | 01/28/2025 | 798 | $51,678 | 100.00% | 0.00% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 357 | $22,123 | 100.00% | 0.00% |
| 02/06/2025 | 14 | $883 | 100.00% | 0.00% | |
| QUANTBOT TECHNOLOGIES LP | 02/11/2025 | 11 | $694 | 100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 8 | $505 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 7 | $442 | -12.50% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Belite Bio, Inc institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Belite Bio, Inc. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 167,930
STATE STREET CORP: 20,017
JPMORGAN CHASE & CO: 14,636
UBS Group AG: 12,207
XTX Topco Ltd: 7,062
GEODE CAPITAL MANAGEMENT, LLC: 6,700
0.92% of Belite Bio, Inc stock is owned by institutional investors.
Institutional investors have bought a total of 268,794 shares in the last 24 months. This purchase volume represents approximately $15.78 M in transactions.